Novartis Pursuing Generic Biologics; Says Brand And Generic Lines Co-Exist

Novartis is positioning itself at the forefront of companies seeking approval of generic biologics with a pending application for human growth hormone

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet